Genetic Characterization of Myoid Hamartoma of the Breast

Conclusion: Myoid hamartoma of the breast may be pathogenetically related to benign connective tissue tumors with HMGA2 rearrangements, such as pulmonary hamartomas, lipomas, myolipomas, and leiomyomas.
Source: Cancer Genomics and Proteomics - Category: Cancer & Oncology Authors: Tags: Article Source Type: research

Related Links:

Condition:   Malignant Neoplasm Interventions:   Drug: Fentanyl Sublingual Spray;   Drug: Morphine;   Other: Physical Performance Testing;   Other: Placebo;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   D011471;   D064129;   D035683;   D009360;   D014408 Intervention:   Diagnostic Test: Periodic ARV7 and miRNA evaluation Sponsor:   Azienda Ospedaliero-Universitaria Careggi Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Locally Advanced Colon Cancer Intervention:   Combination Product: CAPECITABINE AND OXALIPLATIN Sponsor:   Universidad de León Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Patients With Metastatic Colorectal Cancer Interventions:   Drug: Fluoropyrimidine;   Drug: Bevacizumab Sponsor:   Centre Hospitalier Universitaire Dijon Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Breast Cancer Interventions:   Drug: Avelumab;   Drug: Aspirin;   Drug: Lansoprazole Sponsors:   The Christie NHS Foundation Trust;   University of Manchester Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Nutrition;   Physical Activity Interventions:   Behavioral: Intervention Physical Activity;   Other: Usual Care Sponsors:   University of North Carolina, Chapel Hill;   University of Texas Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Neutropenia;   Breast Cancer Interventions:   Drug: Eflapegrastim;   Drug: Docetaxel;   Drug: Cyclophosphamide Sponsor:   Spectrum Pharmaceuticals, Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Non Small Cell Lung Cancer;   Non Small Cell Lung Cancer Metastatic;   Healthy Intervention:   Sponsor:   Indiana University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Neutropenia, Febrile;   Leukemia;   Pediatric Cancer;   Antibiotic Reaction Interventions:   Drug: Ceftazidime Injection;   Drug: Cefepime Injection Sponsor:   Indonesia University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
The objective of this study was to evaluate the diagnostic and prognostic value of 18F-FDG PET/CT in patients with cardiac masses. Methods: Whole-body 18F-FDG PET/CT scans of 64 patients with cardiac masses from August 2012 to August 2018 were retrospectively analyzed (34 men, 30 women; mean age, 51.2±17.5 y). Patients were divided into malignant group and benign group. Quantitative analysis of 18F-FDG uptake (SUVmax, SUVmean, Volume and TLG) of the tumors were performed and was compared between the 2 groups. Receiver operator characteristic (ROC) curve was applied to determine the best cut-off value of differentiat...
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: Other Solid Tumors Posters Source Type: research
More News: Cancer | Cancer & Oncology | Fish | Genetics | Leiomyoma | Lipoma